NK-1/NK-2 antagonists (Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNK-1/NK-2 antagonists (Merck)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 2 receptor antagonistsNeurokinin 1 receptor antagonists
TargetsNeurokinin 2 receptorNeurokinin 1 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A